Immediate-early 2 protein of human cytomegalovirus (IE2)

Immediate-early 2 protein (IE2) of human cytomegalovirus is a nuclear phosphoprotein encoded by the UL122 gene and produced immediately after viral infection from the major immediate-early locus[2][3]. IE2 is essential for activating a broad spectrum of early viral genes, facilitating viral genome replication and lytic infection. Multiple isoforms (notably IE2 p86, p60, and p40) are generated by alternative splicing, but all share a conserved DNA-binding and dimerization domain[2]. IE2 functions as a master regulator by interacting directly with viral chromatin, RNA polymerase II, and various host and viral proteins, including TBP, TFIIB, and UL84[2]. It exhibits both positive and negative regulatory roles: it transactivates early viral genes and represses its own promoter, thereby balancing viral gene expression for productive infection[2][3]. IE2 activity is crucial for HCMV pathogenesis, particularly in immunocompromised individuals, but its essential and cytotoxic nature makes direct targeting therapeutically challenging.

Other names

IE2UL122 gene productHCMV IE2Immediate-early 2 of HCMV

Transcription inhibitor (hypothetical, for drugs that inhibit IE2 function); Disruption of IE2 DNA binding or protein-protein interactions (hypothetical, research stage)